Gene expression profiling of large cohorts of MBs has dissected this historically monomorphous tumor entity into four distinct molecular subgroups (WNT, SHH, group 3, and group 4) with divergent prognoses and responses to therapy (Taylor et al., 2012). The gene discussed is SHH; the disease is Mobius syndrome.